nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Ketonuria—Metformin—metabolic syndrome X	0.164	0.334	CcSEcCtD
Naratriptan—Almotriptan—FMO3—metabolic syndrome X	0.0567	1	CrCbGaD
Naratriptan—HTR1B—artery—metabolic syndrome X	0.0245	0.176	CbGeAlD
Naratriptan—HTR1D—artery—metabolic syndrome X	0.0237	0.17	CbGeAlD
Naratriptan—HTR1B—blood vessel—metabolic syndrome X	0.0191	0.137	CbGeAlD
Naratriptan—HTR1D—blood vessel—metabolic syndrome X	0.0185	0.133	CbGeAlD
Naratriptan—Blood disorder—Metformin—metabolic syndrome X	0.0185	0.0377	CcSEcCtD
Naratriptan—Migraine—Metformin—metabolic syndrome X	0.011	0.0225	CcSEcCtD
Naratriptan—Dehydration—Metformin—metabolic syndrome X	0.0104	0.0213	CcSEcCtD
Naratriptan—Liver function test abnormal—Metformin—metabolic syndrome X	0.0103	0.0211	CcSEcCtD
Naratriptan—Cramp muscle—Metformin—metabolic syndrome X	0.0101	0.0206	CcSEcCtD
Naratriptan—Angina pectoris—Metformin—metabolic syndrome X	0.00942	0.0193	CcSEcCtD
Naratriptan—Abdominal discomfort—Metformin—metabolic syndrome X	0.00927	0.019	CcSEcCtD
Naratriptan—Drowsiness—Metformin—metabolic syndrome X	0.00862	0.0176	CcSEcCtD
Naratriptan—HTR1B—cardiovascular system—metabolic syndrome X	0.00852	0.0611	CbGeAlD
Naratriptan—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00845	0.0173	CcSEcCtD
Naratriptan—HTR1D—cardiovascular system—metabolic syndrome X	0.00825	0.0592	CbGeAlD
Naratriptan—HTR1D—kidney—metabolic syndrome X	0.00807	0.0579	CbGeAlD
Naratriptan—Bradycardia—Metformin—metabolic syndrome X	0.00788	0.0161	CcSEcCtD
Naratriptan—Hypoaesthesia—Metformin—metabolic syndrome X	0.0077	0.0158	CcSEcCtD
Naratriptan—Cardiac disorder—Metformin—metabolic syndrome X	0.00718	0.0147	CcSEcCtD
Naratriptan—Angiopathy—Metformin—metabolic syndrome X	0.00702	0.0144	CcSEcCtD
Naratriptan—Immune system disorder—Metformin—metabolic syndrome X	0.00699	0.0143	CcSEcCtD
Naratriptan—Chills—Metformin—metabolic syndrome X	0.00695	0.0142	CcSEcCtD
Naratriptan—HTR1A—cardiovascular system—metabolic syndrome X	0.00688	0.0493	CbGeAlD
Naratriptan—Erythema—Metformin—metabolic syndrome X	0.00674	0.0138	CcSEcCtD
Naratriptan—Muscle spasms—Metformin—metabolic syndrome X	0.00648	0.0132	CcSEcCtD
Naratriptan—Vision blurred—Metformin—metabolic syndrome X	0.00635	0.013	CcSEcCtD
Naratriptan—Tremor—Metformin—metabolic syndrome X	0.00631	0.0129	CcSEcCtD
Naratriptan—MAOA—cardiovascular system—metabolic syndrome X	0.00628	0.0451	CbGeAlD
Naratriptan—Ill-defined disorder—Metformin—metabolic syndrome X	0.00625	0.0128	CcSEcCtD
Naratriptan—MAOA—kidney—metabolic syndrome X	0.00615	0.0441	CbGeAlD
Naratriptan—Malaise—Metformin—metabolic syndrome X	0.00608	0.0124	CcSEcCtD
Naratriptan—Syncope—Metformin—metabolic syndrome X	0.00604	0.0124	CcSEcCtD
Naratriptan—Palpitations—Metformin—metabolic syndrome X	0.00595	0.0122	CcSEcCtD
Naratriptan—Loss of consciousness—Metformin—metabolic syndrome X	0.00592	0.0121	CcSEcCtD
Naratriptan—Myalgia—Metformin—metabolic syndrome X	0.00574	0.0117	CcSEcCtD
Naratriptan—Discomfort—Metformin—metabolic syndrome X	0.00567	0.0116	CcSEcCtD
Naratriptan—MAOA—adipose tissue—metabolic syndrome X	0.00554	0.0397	CbGeAlD
Naratriptan—Oedema—Metformin—metabolic syndrome X	0.0055	0.0112	CcSEcCtD
Naratriptan—Infection—Metformin—metabolic syndrome X	0.00546	0.0112	CcSEcCtD
Naratriptan—Shock—Metformin—metabolic syndrome X	0.00541	0.0111	CcSEcCtD
Naratriptan—Nervous system disorder—Metformin—metabolic syndrome X	0.00539	0.011	CcSEcCtD
Naratriptan—Thrombocytopenia—Metformin—metabolic syndrome X	0.00538	0.011	CcSEcCtD
Naratriptan—Skin disorder—Metformin—metabolic syndrome X	0.00534	0.0109	CcSEcCtD
Naratriptan—Hyperhidrosis—Metformin—metabolic syndrome X	0.00532	0.0109	CcSEcCtD
Naratriptan—Hypotension—Metformin—metabolic syndrome X	0.00514	0.0105	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00501	0.0102	CcSEcCtD
Naratriptan—Paraesthesia—Metformin—metabolic syndrome X	0.00494	0.0101	CcSEcCtD
Naratriptan—Dyspnoea—Metformin—metabolic syndrome X	0.0049	0.01	CcSEcCtD
Naratriptan—Somnolence—Metformin—metabolic syndrome X	0.00489	0.01	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00475	0.00971	CcSEcCtD
Naratriptan—Fatigue—Metformin—metabolic syndrome X	0.00474	0.0097	CcSEcCtD
Naratriptan—Constipation—Metformin—metabolic syndrome X	0.0047	0.00962	CcSEcCtD
Naratriptan—Feeling abnormal—Metformin—metabolic syndrome X	0.00453	0.00927	CcSEcCtD
Naratriptan—Urticaria—Metformin—metabolic syndrome X	0.00437	0.00893	CcSEcCtD
Naratriptan—Asthenia—Metformin—metabolic syndrome X	0.00395	0.00807	CcSEcCtD
Naratriptan—Pruritus—Metformin—metabolic syndrome X	0.00389	0.00796	CcSEcCtD
Naratriptan—MAOA—liver—metabolic syndrome X	0.00388	0.0279	CbGeAlD
Naratriptan—Diarrhoea—Metformin—metabolic syndrome X	0.00376	0.00769	CcSEcCtD
Naratriptan—Dizziness—Metformin—metabolic syndrome X	0.00364	0.00744	CcSEcCtD
Naratriptan—Vomiting—Metformin—metabolic syndrome X	0.0035	0.00715	CcSEcCtD
Naratriptan—Rash—Metformin—metabolic syndrome X	0.00347	0.00709	CcSEcCtD
Naratriptan—Dermatitis—Metformin—metabolic syndrome X	0.00346	0.00708	CcSEcCtD
Naratriptan—Headache—Metformin—metabolic syndrome X	0.00345	0.00705	CcSEcCtD
Naratriptan—Nausea—Metformin—metabolic syndrome X	0.00327	0.00668	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—GHRL—metabolic syndrome X	0.00083	0.00264	CbGpPWpGaD
Naratriptan—HTR1B—G alpha (i) signalling events—AGT—metabolic syndrome X	0.000825	0.00262	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.000813	0.00258	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—GHRL—metabolic syndrome X	0.000813	0.00258	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.0008	0.00254	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—AGT—metabolic syndrome X	0.000797	0.00253	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—CNR1—metabolic syndrome X	0.000786	0.0025	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000784	0.00249	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000774	0.00246	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00077	0.00245	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CNR1—metabolic syndrome X	0.00077	0.00245	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—CCL5—metabolic syndrome X	0.000751	0.00238	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000734	0.00233	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000703	0.00223	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000695	0.00221	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—FMO3—metabolic syndrome X	0.000681	0.00216	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00067	0.00213	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—GHRL—metabolic syndrome X	0.000666	0.00212	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—CCL2—metabolic syndrome X	0.000657	0.00209	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000656	0.00208	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000653	0.00207	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000635	0.00202	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CNR1—metabolic syndrome X	0.000631	0.002	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—AGT—metabolic syndrome X	0.000628	0.00199	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000622	0.00198	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—GHRL—metabolic syndrome X	0.000619	0.00197	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—CCL5—metabolic syndrome X	0.00061	0.00194	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MLXIPL—metabolic syndrome X	0.000607	0.00193	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—EPHX2—metabolic syndrome X	0.000607	0.00193	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000597	0.0019	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CCL5—metabolic syndrome X	0.000597	0.0019	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HDAC3—metabolic syndrome X	0.000596	0.00189	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CNR1—metabolic syndrome X	0.000587	0.00186	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000577	0.00183	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—G6PC2—metabolic syndrome X	0.000571	0.00181	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000565	0.00179	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000551	0.00175	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00054	0.00171	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000539	0.00171	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000533	0.00169	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TRIB3—metabolic syndrome X	0.000519	0.00165	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—RBP4—metabolic syndrome X	0.000519	0.00165	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—AGT—metabolic syndrome X	0.00051	0.00162	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000499	0.00159	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—AGT—metabolic syndrome X	0.000499	0.00159	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000495	0.00157	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CCL5—metabolic syndrome X	0.000489	0.00155	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000487	0.00155	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—FABP4—metabolic syndrome X	0.000485	0.00154	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000485	0.00154	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000474	0.00151	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000469	0.00149	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.000465	0.00148	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOC3—metabolic syndrome X	0.00046	0.00146	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—HSD11B1—metabolic syndrome X	0.00046	0.00146	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00046	0.00146	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CCL5—metabolic syndrome X	0.000455	0.00144	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—AGT—metabolic syndrome X	0.000451	0.00143	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00045	0.00143	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000444	0.00141	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00044	0.0014	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000435	0.00138	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00043	0.00137	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—GHRL—metabolic syndrome X	0.000426	0.00135	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—CCL2—metabolic syndrome X	0.00042	0.00133	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—GHRL—metabolic syndrome X	0.000417	0.00133	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2C—metabolic syndrome X	0.000415	0.00132	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000411	0.00131	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CCL2—metabolic syndrome X	0.000411	0.00131	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—G6PD—metabolic syndrome X	0.00041	0.0013	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—AGT—metabolic syndrome X	0.000409	0.0013	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CNR1—metabolic syndrome X	0.000404	0.00128	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CYBA—metabolic syndrome X	0.000402	0.00128	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—HDAC3—metabolic syndrome X	0.0004	0.00127	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CNR1—metabolic syndrome X	0.000395	0.00125	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.000395	0.00125	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—GHRL—metabolic syndrome X	0.000394	0.00125	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GCKR—metabolic syndrome X	0.000391	0.00124	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—LPA—metabolic syndrome X	0.000391	0.00124	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HDAC3—metabolic syndrome X	0.000381	0.00121	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—AGT—metabolic syndrome X	0.00038	0.00121	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PLA2G6—metabolic syndrome X	0.000379	0.0012	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	0.000375	0.00119	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOA5—metabolic syndrome X	0.000375	0.00119	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HDAC3—metabolic syndrome X	0.000373	0.00119	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CNR1—metabolic syndrome X	0.000373	0.00118	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000369	0.00117	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00035	0.00111	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—TRIB3—metabolic syndrome X	0.000349	0.00111	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000344	0.00109	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000341	0.00108	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000337	0.00107	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CCL2—metabolic syndrome X	0.000337	0.00107	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000335	0.00106	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000334	0.00106	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TRIB3—metabolic syndrome X	0.000332	0.00105	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RBP4—metabolic syndrome X	0.000332	0.00105	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000331	0.00105	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TRIB3—metabolic syndrome X	0.000325	0.00103	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RBP4—metabolic syndrome X	0.000325	0.00103	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	0.000319	0.00101	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—GHRL—metabolic syndrome X	0.000318	0.00101	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CCL2—metabolic syndrome X	0.000313	0.000995	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCL5—metabolic syndrome X	0.000313	0.000993	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NAMPT—metabolic syndrome X	0.000313	0.000993	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000312	0.00099	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—LIPC—metabolic syndrome X	0.000311	0.000987	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GCK—metabolic syndrome X	0.000311	0.000987	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOC3—metabolic syndrome X	0.000309	0.000981	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL5—metabolic syndrome X	0.000306	0.000973	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000305	0.000969	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF2—metabolic syndrome X	0.000305	0.000968	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CNR1—metabolic syndrome X	0.000301	0.000956	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CETP—metabolic syndrome X	0.0003	0.000952	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOB—metabolic syndrome X	0.000296	0.00094	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOC3—metabolic syndrome X	0.000294	0.000934	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL5—metabolic syndrome X	0.000289	0.000918	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AGT—metabolic syndrome X	0.000288	0.000915	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOC3—metabolic syndrome X	0.000288	0.000915	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000288	0.000914	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—SCARB1—metabolic syndrome X	0.000287	0.000912	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HDAC3—metabolic syndrome X	0.000284	0.000903	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—LPL—metabolic syndrome X	0.000283	0.000897	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AGT—metabolic syndrome X	0.000282	0.000896	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—SREBF1—metabolic syndrome X	0.000279	0.000885	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—HMGCR—metabolic syndrome X	0.000271	0.000861	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GOT2—metabolic syndrome X	0.000271	0.000861	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2C—metabolic syndrome X	0.000266	0.000843	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AGT—metabolic syndrome X	0.000262	0.000831	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2C—metabolic syndrome X	0.00026	0.000826	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CYBA—metabolic syndrome X	0.000257	0.000817	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000257	0.000816	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AGT—metabolic syndrome X	0.000256	0.000814	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000254	0.000807	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CYBA—metabolic syndrome X	0.000252	0.0008	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GHRL—metabolic syndrome X	0.000252	0.000799	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TRIB3—metabolic syndrome X	0.000248	0.000787	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RBP4—metabolic syndrome X	0.000248	0.000787	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GHRL—metabolic syndrome X	0.000247	0.000783	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AGT—metabolic syndrome X	0.000242	0.000768	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ABCA1—metabolic syndrome X	0.000242	0.000767	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—SLC2A4—metabolic syndrome X	0.000242	0.000767	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CNR1—metabolic syndrome X	0.000238	0.000757	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOE—metabolic syndrome X	0.000237	0.000752	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—LEP—metabolic syndrome X	0.000237	0.000752	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOA1—metabolic syndrome X	0.000234	0.000743	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GOT1—metabolic syndrome X	0.000234	0.000743	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GGT1—metabolic syndrome X	0.000234	0.000743	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CNR1—metabolic syndrome X	0.000233	0.000741	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL5—metabolic syndrome X	0.000233	0.000741	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000232	0.000738	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOC3—metabolic syndrome X	0.000219	0.000697	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCL2—metabolic syndrome X	0.000215	0.000684	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000215	0.000683	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IRS1—metabolic syndrome X	0.000211	0.000671	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL2—metabolic syndrome X	0.000211	0.00067	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—INS—metabolic syndrome X	0.000202	0.000642	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL2—metabolic syndrome X	0.000199	0.000632	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOB—metabolic syndrome X	0.000199	0.000631	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000198	0.000629	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF1—metabolic syndrome X	0.000196	0.000621	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AGT—metabolic syndrome X	0.000195	0.00062	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF2—metabolic syndrome X	0.000195	0.000619	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PLA2G4A—metabolic syndrome X	0.000193	0.000613	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CYBA—metabolic syndrome X	0.000192	0.000609	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF2—metabolic syndrome X	0.000191	0.000606	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—LPL—metabolic syndrome X	0.00019	0.000602	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOB—metabolic syndrome X	0.000189	0.000601	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GHRL—metabolic syndrome X	0.000188	0.000596	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000186	0.00059	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOB—metabolic syndrome X	0.000185	0.000588	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL5—metabolic syndrome X	0.000185	0.000587	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000184	0.000585	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL5—metabolic syndrome X	0.000181	0.000575	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LPL—metabolic syndrome X	0.000181	0.000574	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00018	0.000572	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CD36—metabolic syndrome X	0.00018	0.000572	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CNR1—metabolic syndrome X	0.000178	0.000565	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NOS3—metabolic syndrome X	0.000177	0.000563	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LPL—metabolic syndrome X	0.000177	0.000562	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARA—metabolic syndrome X	0.000167	0.000532	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AGT—metabolic syndrome X	0.000162	0.000515	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000161	0.00051	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOE—metabolic syndrome X	0.000159	0.000505	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOA1—metabolic syndrome X	0.000157	0.000499	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AGT—metabolic syndrome X	0.000155	0.000491	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000152	0.000483	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LEP—metabolic syndrome X	0.000151	0.000481	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOE—metabolic syndrome X	0.000151	0.000481	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AGT—metabolic syndrome X	0.000151	0.000481	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOA1—metabolic syndrome X	0.00015	0.000475	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—metabolic syndrome X	0.00015	0.000475	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOE—metabolic syndrome X	0.000148	0.000471	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LEP—metabolic syndrome X	0.000148	0.000471	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOA1—metabolic syndrome X	0.000147	0.000466	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF2—metabolic syndrome X	0.000145	0.000462	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOB—metabolic syndrome X	0.000141	0.000448	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARG—metabolic syndrome X	0.000138	0.00044	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—AKT1—metabolic syndrome X	0.000138	0.000438	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL5—metabolic syndrome X	0.000138	0.000438	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000137	0.000436	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—INS—metabolic syndrome X	0.000136	0.000431	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IRS1—metabolic syndrome X	0.000135	0.000429	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LPL—metabolic syndrome X	0.000135	0.000428	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IRS1—metabolic syndrome X	0.000132	0.00042	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—INS—metabolic syndrome X	0.000129	0.000411	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL2—metabolic syndrome X	0.000127	0.000404	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—INS—metabolic syndrome X	0.000127	0.000402	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF1—metabolic syndrome X	0.000125	0.000397	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL2—metabolic syndrome X	0.000125	0.000396	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ALB—metabolic syndrome X	0.000124	0.000395	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF1—metabolic syndrome X	0.000123	0.000389	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NOS3—metabolic syndrome X	0.000119	0.000378	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000119	0.000377	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TGFB1—metabolic syndrome X	0.000117	0.000373	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000116	0.00037	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AGT—metabolic syndrome X	0.000115	0.000366	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOS3—metabolic syndrome X	0.000113	0.00036	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LEP—metabolic syndrome X	0.000113	0.000359	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOE—metabolic syndrome X	0.000113	0.000359	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOA1—metabolic syndrome X	0.000112	0.000355	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOS3—metabolic syndrome X	0.000111	0.000353	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—metabolic syndrome X	0.000109	0.000346	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IRS1—metabolic syndrome X	0.000101	0.00032	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AKT1—metabolic syndrome X	9.72e-05	0.000309	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—INS—metabolic syndrome X	9.65e-05	0.000306	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—metabolic syndrome X	9.57e-05	0.000304	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AKT1—metabolic syndrome X	9.52e-05	0.000302	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	9.5e-05	0.000302	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—metabolic syndrome X	9.37e-05	0.000298	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	9.33e-05	0.000296	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.86e-05	0.000282	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—metabolic syndrome X	8.84e-05	0.000281	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AKT1—metabolic syndrome X	8.83e-05	0.00028	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	8.65e-05	0.000275	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	8.46e-05	0.000269	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AKT1—metabolic syndrome X	8.16e-05	0.000259	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	7.5e-05	0.000238	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	7.35e-05	0.000233	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.25e-05	0.00023	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	7.14e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	6.59e-05	0.000209	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	5.65e-05	0.00018	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	5.6e-05	0.000178	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	5.54e-05	0.000176	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AKT1—metabolic syndrome X	5.47e-05	0.000174	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	5.22e-05	0.000166	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	5.11e-05	0.000162	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	4.22e-05	0.000134	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	3.89e-05	0.000124	CbGpPWpGaD
